Overview

Arthropod-borne Viral Infections Testing Market Dynamics:

The arboviral infections are caused by viruses spread by the bite of an arthropod like mosquito or tick. Instances of arboviruses are yellow fever, chikungunya, St. Louis encephalitis, dengue, eastern equine encephalitis, California encephalitis, zika, Western Nile and Powassan. There are over 130 types of arthropod borne viral infections that affect humans. People generally suffer with no symptoms or mild symptoms like skin rash, headache, etc. The arbovirus diagnostics is capable of detecting the antibodies that are produced by the immune system while responding to a specific arbovirus. The rising expenditure in public healthcare, increased prevalence of arbovirus diseases are some of the key factors responsible for the arthropod-borne viral infections testing market growth.

Arthropod-borne Viral Infections Testing Market Segmentation:

By Test Type
•   Molecular Tests
•   Cultural Tests
•   Immunoassays
•   Others
By End User
•   Hospitals
•   Research Centers
•   Diagnostic Centers
By Region
•   North America
•   Europe
•   Asia Pacific
•   Latin America
•   Middle East & Africa
The market is classified into test type, end user and region. The test type segment is fragmented into molecular tests, culture tests, immunoassays and others. The molecular test segment is predicted to hold the largest arthropod borne viral infections testing market share owing to its high ability and accuracy of diagnosing diseases within a short time span. The end user segment is diversified into hospitals, research centres, diagnostic laboratories and others. The hospital segment is anticipated to lead the market during the forecast period owing to advancements in the hospital infrastructure and the availability of skilled professionals.
Regional Analysis:
The North America region is expected to subjugate the market owing to the rising geriatric population, rising occurrence of arbovirus and a strong presence of key players in the region. Furthermore, the higher acceptance of diagnostic tests, increased expenditure on healthcare have boosted the market growth in this region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period and this can be attributed to the rising patient population, growing awareness regarding arbovirus diseases, improving healthcare infrastructure.

Competitive Landscape:
Some of the major market players associated are Abbott, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, bioMerieux SA, Hologic Inc., MedMira Inc., QIAGEN, Roche Molecular Systems Inc., Danaher Corporation, Siemens Healthineers, Thermo Fisher Scientific Inc.

FutureWise Key Takeaways:
•   Growth prospects
•   SWOT analysis
•   Key market trends
•   Key data-points affecting market growth

Objectives of the Study:
•   To provide with an exhaustive analysis on the global arthropod-borne viral infections testing market by test type, by end user and by region
•   To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•   To evaluate and forecast micro-markets and the overall market
•   To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•   To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com